Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma

Clinical Cancer Research

Volumn 2, Issue 8, 1996, Pages 1361-1367

  Kramer, Kim ^a   Gerald, William ^a   LeSauteur, Lynne ^b   Saragovi, H Uri ^b,c   Cheung, Nai Kong V ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY CD3;

ARTICLE; CELL DIFFERENTIATION; DIAGNOSTIC VALUE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERNALIZATION; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN DOMAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; GENE DOSAGE; GENES, MYC; HUMANS; IMMUNOHISTOCHEMISTRY; NEUROBLASTOMA; PROGNOSIS; RECEPTOR, TRKA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0029761987     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Matsushima, H., and Bogenmann, E. Nerve growth factor (NGF) induces neuronal differentiation in neuroblastoma cells transfected with the NGF Receptor cDNA. Mol. Cell Biol., 10. 5015-5020, 1990.
2. Yankner, B. A., and Shooter, E. M. The biology and mechanism of action of nerve growth factor. Ann. Rev. Biochem., 51: 845-868, 1982.
3. Loeb, D. M., Maragos, J., Martin-Zanca, D., Zanca, D., Chao, M. V., Parada, L. F., and Greene, L. A. The Trk proto-onocogene rescues NGF responsiveness in mutant NGF nonresponsive PC12 cell lines. Cell, 66: 961-966, 1991.
4. Cordon-Cardo, C., Tapley, P., Jing, S. O., Nanduri, V., O'Rourke, E., Lamballe, F., Kovary, K., Klein, R., Jones, K. R., and Reichardt, L. F. The trk tyrosine protein kinase mediates the mitogenic properties of NGF and neurotrophin 3. Cell, 66: 173-183, 1991.
5. Smeyne, R. J., Klein, R., and Schnapp, A. Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature (Lond.), 368: 246-249, 1994.
6. Nakagawara, A., Arima-Nakagawara, M., Scavarda, N. J., Azar, C. G., Cantor, A. B., and Brodeur, G. M. Association between high levels of expression of Trk gene and favorable outcome in human neuroblastoma. N. Engl. J. Med , 328: 847-854, 1993.
7. Suzuki, T., Bogenmann, E., Shimada, M., Stram, D., and Seeger, R. C. Lack of high affinity nerve growth receptors in aggressive neuroblastoma J. Natl. Cancer Inst., 85: 377-384, 1993.
8. Matsushima, H., and Bogenmann, E. Expression of trkA cDNA in neuroblastomas mediates differentiation in vitro and in vivo. Mol. Cell Biol., 13: 7447-7456, 1993.
9. LeSauteur, L., Malarchuk, S., LeJeune, H., and Saragovi, H. U. Potent human p140-TrkA agonists derived from an anti-receptor monoclonal antibody. J. Neurosci., 16: 1308-1316, 1996.
10. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
11. Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Siegel, S. E., Wong, K. Y., and Hammond, D. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med., 313: 1111-1116, 1985.
12. Crabbe, D. C. G., Peters, J., and Seeger, R. C. Rapid detection of MYCN gene amplification in neuroblastomas using the polymerase chain reaction. Diagn. Mol. Pathol , 1: 229-234, 1992.
13. Kaplan, E. L., and Meier, P. Nonparameters estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
14. Mantel, H., and Haenzel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst , 22: 719-748, 1959.
15. Boulton, A. A., Baker, G. B., and Hefti, F. (eds.). Neuromethods 25: Neurotrophic Factors. Totawa, NJ: Humana Press, 1993.
16. Nakagawara, A. Milbrandt, J., Muramatsu, T., Deuel, T. F., Zhao, H., Cnaan, A., and Brodeur G. M. Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res., 55: 1792-1797, 1995.
17. Nakagawara, A., Azar, C., Scavarda, N. J., and Brodeur, G. M. Expression and function of Trk-B and BDNF in human neuroblastomas. Mol. Cell Biol., 14: 759-767, 1994.
18. Matsumoto, K., Wada, R. K , Yamashiro, J. M., Kaplan, D. R., and Thiele, C. J. Expression of brain-derived neurotrophic factor and p145TrkB affects survival differentiation, and invasiveness of human neuroblastoma cells. Cancer Res., 55: 1798-1806, 1995.
19. Bogenmann, E., Torres, M., and Matsushima, H Constitutive N-myc gene expression inhibits TrkA mediated neuronal differentiation. Oncogene, 10: 1915-1925, 1995.
20. Dominici, C., Nicotra, M. R., Digiesi, G., McDowell, H., Alema, S., Padula, A., Gargano, N., Donfrancesco, M. A., Castello, M. A., and Natali, P. G. Immunohistochemical detection of high-affinity nerve growth factor receptor in neuroblastoma. Eur. J. Cancer., 31A: 444-446, 1995
21. Nakagawara, A., Arima, M., Azar, C., Scavarda, N. J., and Brodeur, G. M. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. Cancer Res., 52: 1364-1368, 1992.
22. Kogner, P., Barbany, G., Dominici, C., Castello, M. A., Raschella, G., and Persson, H. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res., 53: 2044-2050, 1993.
23. Borrello, M. G., Bongarzone, I., Pierotti, M. A., Luksch, R., Gosparini, M., Collini, P., Pilotti, S., Rizzetti, M. G., Mondellini, P., and DeBernardi, B. TrK and ret proto-oncogene expression in human NB specimens: high frequency of TrK expression in nonadvanced stages. Int. J. Cancer, 54: 540-545, 1993.
24. Tanaka, T., Hiyama, E., Sugimoto, T., Sawada, T., Tanabe, M., and Ida, N. TrkA gene expression in neuroblastoma. Cancer (Phila.), 76: 1086-1095, 1995.
25. LeSauteur, L., Wei, L., Gibbs, B. F., and Saragovi, H. U. Small peptide mimics of nerve growth factor bind TrkA receptors and affect biological responses. J. Biol. Chem., 270: 6564-6569, 1995.
26. Berthold, F., Harms, D., Lampert, F., Michaela, J., Niethammer, D., and Zieschang, J. Risk factors in neuroblastoma of infants. Contrib. Oncol , 41: 101-117, 1990.
27. Carlsen, N. L. T. Why age has independent prognostic significance in neuroblastoma: evidence of intrauterine development and implications for the treatment of disease. Anticancer Res., 8: 255-262, 1988.
28. Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E., and Biship, J. M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science (Washington DC), 224: 1121-1124, 1984.
29. Hayashi, Y., Kanda, N., Inaba, T., Hanada, R., Nagahara, N., Muchi, H., and Yamamoto, K. Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer (Phila.) 63: 126-132, 1989.
30. Favrot, M. C., Combaret, V., and Lasset, C. CD44: a new prognostic marker for neuroblastoma. N. Engl. J. Med., 329: 1965, 1994.
31. Gross, N., Beretta, C., Peruisseau, G., Jackson, D., Simmons, D., and Beck, D. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation. Cancer Res., 54: 4238-4242, 1994.
32. Look, A T., Hayes, F. A., Nitschke, R., McWilliams, N. B., and Green, A. A. Cellular DNA content as a prediction of response to chemotherapy in infants with unresectable neuroblastoma. N. Engl. J. Med., 311: 231-235, 1984.
33. Look, A. T., Hayes, F. A., Shuster, J. J., Douglass, E. C., Castleberry, R. P., Bowman, L. C., Smith, E., and Brodeur, G. M. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J. Clin. Oncol., 9: 581-591, 1991.
34. Shimada, H., Chatten, J., Newton, W. A., Sachs, N., Hamondi, A. B., Chiba, T., Marsden, H. B., and Misugi, K. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J. Natl. Cancer Inst., 73: 405-416, 1984.